The recent results from the TAILORx study (a major study published by The New England Journal of Medicine and presented at a meeting of the American Society of Clinical Oncology) means that certain women with particular genomic profiling and early stage breast cancer can safely forgo postsurgical chemotherapy. This is terrific news and a… Read More
